Press release
Equine Healthcare Market Insights, Opportunity Analysis, and Industry Forecast till 2025
Request for sample copy : https://www.coherentmarketinsights.com/insight/request-sample/835
High return on investment and rise in genotypic analyzers is expected to lead the market expansion
Equine veterinary practice is expected to be a high overhead owing to prevent the rising diseases like influenza virus, herpes virus, west nile virus and encephalomyelitis, where the cost for global vaccination is estimated to be around 30 million dollars by the Euro Surveillance Journal in 2016. Rising investments and popularity in alternative forms of gambling like horse racing, online gaming, betting, competitive riding, high return on investment and leisure is expected to drive the global equine healthcare market. The growth and rising demand for gestation diagnosis products, increasing urine test kits, ultrasound devices and supplement products will boost the global equine healthcare market. Additionally, the growing initiatives by equine healthcare organizations to develop drugs for various diseases is expected to give impetus to the equine healthcare market. The non-invasive test kits are largely preferred by the veterinarians owing to the easy usage and affordability.
Rising demand for equine diagnostic products is expected to boost equine healthcare market
The global equine healthcare market is segmented on the basis of diagnostic products, therapeutic products, supplementary products and geography.
On the basis of diagnostic products, the global equine healthcare market is segmented into:
Pregnancy and Gestation Diagnostic
Urine Test Kits
Ultrasound Devices
Genotyping Analysis
Breed Quality Analyzers
Semen Quality Analyzers
Genetic Disease Identification Products
On the basis of therapeutic products, the global equine healthcare market is segmented into:
Dopamine Agonists
Vaccines
Anti-Bacterial
Anti-Protozoal
Anti-Viral
Laxatives
Anti-Inflammatory
On the basis of supplement products, the global equine healthcare market is segmented into:
Performance Supplements
Proteins and Amino Acids
Electrolytes
Vitamins
Others
Protection Supplement
Protection Products
Prosthetics
Request for table of content : https://www.coherentmarketinsights.com/ongoing-insight/toc/835
Asia Pacific market is expected to show positive growth owing to the import of quality of quality breeds and their maintenance
Regional segmentation of the equine healthcare market by Coherent Market Insights comprises of North America, Europe, Asia Pacific, Latin America, Middle East and Africa. According to the study conducted by the American Horse Council in 2004, U.S. has 9.2 million horses with $39 billion direct economic impact. Also, a total 22,849 horses were imported into the U.S. in 2013, thereby increasing the demand of equine healthcare in North America. The Australian market is among the leading horse breeding countries of Asia Pacific, hence contributing to the drastically increasing demand for healthcare products in Asia Pacific. Additionally, the maintenance of race-horse breeds by the rising investments from China by specific supplements, therapeutic and protection products drive the growth of Asia Pacific market.
Animal-health innovation driven acquisition broadens global equine healthcare market
Key players operating the equine healthcare market include Affymetrix Inc., Boehringer Ingelheim, Merck, Bayer Health Care and Elanco Animal Health. The agreement of Sanofi with Bayer equine health to launch a variety of products to prevent gastric ulcer syndrome, westnile virus, equine influenza and rabies in horses. The launch of updated equine influenza vaccine ProteqFlu by Merial broadens the portfolio of leading products. Other prominent Vendors include Vetoquinol, Novartis Animal Health, Ceva Holdings and Signostics.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Equine Healthcare Market Insights, Opportunity Analysis, and Industry Forecast till 2025 here
News-ID: 785809 • Views: …
More Releases from Pharmaceutical Report By CMI
Rising prevalence of diabetes is a major factor driving growth of the diabetic f …
Diabetic foot ulcers is a common condition in diabetic patients. It is a disabling disorder, which might lead to amputation of the leg. Mortality due to diabetic foot ulcers is high and chances of recurrence of cured foot ulcers is also high and this in turn leads to increasing demand for proper treatment of diabetic foot ulcers. Diabetic foot ulcer is caused due to neuropathic and vascular changes in the…
Glucagon-Like Peptide-1 (Glp-1) Analogs Market Global Industry Insights, Trends, …
Glucagon-like peptide-1 (GLP-1) analogs also known as incretin mimetics are class of drugs indicated for type-2 diabetes mellitus to lower the blood sugar level. GLP-1 analogs prevents the breakdown of GLP-1, thereby enhancing the glucose depended insulin release, suppresses the glucagon release (which reduces hepatic glucose output), and reduces gastric emptying rate (resulting in weight loss from reduced appetite). GLP-1 analogs do not cause hypoglycemia like other class of anti-diabetic…
Multiple Sclerosis Therapeutics Market to Surpass US$ 24.4 Billion by 2025
Increasing prevalence of multiple sclerosis to augment market growth
Multiple sclerosis is a widespread disabling neurological condition, mostly diagnosed in people in the age group 20–50 years. According to the Multiple Sclerosis Foundation, 2017, this autoimmune condition affects 2.5 million people with the global incidence of around 7 cases per 100,000 people per year. The study also states that prevalence rates varies between ethnic and geographical latitudes, ranging from 50 to…
Diabetic Foot Ulcers Treatment Market to Surpass US$ 9.49 Billion Threshold by 2 …
Diabetic foot ulcers is a common condition in diabetic patients. It is a disabling disorder, which might lead to amputation of the leg. Mortality due to diabetic foot ulcers is high and chances of recurrence of cured foot ulcers is also high and this in turn leads to increasing demand for proper treatment of diabetic foot ulcers. Diabetic foot ulcer is caused due to neuropathic and vascular changes in the…
More Releases for Equine
Equine Supplement Products Market Aims to Expand at Double-Digit Growth Rate Cov …
A new detailed report named as Global Equine Supplement Products market is released now for the benefit of the market players. This report is highly based on the elaborate market study. Information on the recent market trends, current market scenario and market growth is an important instrument to grow and survive in the ever-evolving competitive industry. It helps the new layers to develop a constant strategy which is flexible to…
Equine Supplement Products Market Worth US$ 1,15,932.42 thousand by 2028 | Plusv …
According to our new market research study on “Equine Supplement Products Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Supplements, Application, Distribution Channel, and Geography,” the market is expected to reach US$ 1,15,932.42 Thousand in 2028 from US$ 89,436.31 Thousand in 2021. The market is estimated to grow with a CAGR of 3.8% from 2021-2028. Key factors that are driving growth of the market are benefits…
Global Equine Supplement Products Market 2020 Business Strategies – Bayer AG, …
The market report titled “Equine Supplement Products Market: by Supplement (Proteins/ Amino Acids, Vitamins, Enzymes, Electrolytes/ Minerals, and Others), by Application (Performance Enhancement, Joint Disorder Prevention, and Others), and by Distribution Channel (Veterinary Hospital Pharmacies, Retail Pharmacies, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2025” and published by Zion Market Research will put forth a systematizedevaluation of the vital facets of the global Equine Supplement Products…
Equine Healthcare Market Projections 2017 - 2025
Presence of large numbers of players engaged in manufacturing of equine healthcare products renders the global market increasingly fragmented. The players span across geographies, and are targeting geographic expansion as a part of the key strategies in the equine healthcare market. A number of regional markets have gathered momentum over the past few years. Asia Pacific has been offering new streams of revenues to key players in the equine healthcare…
Equine Supplement Products Market |Industry Key Players - Zoetis, Boehringer Ing …
This report analyzes the current and future scenario of the global equine supplement products market. Increase in interest in gambling, horse racing, and sports, rise in prevalence of equine infections and surge in demand for animal feeds containing electrolytes and minerals are anticipated to drive the market during the forecast period. Furthermore, new product launch by market players, surge in government initiatives toward equine health, and increase in awareness about…
Global Equine Pharmaceuticals and Supplements Market 2019 - Virbac, Norbrook Equ …
Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.
Get Free Sample Copy of Report Here: http://bit.ly/2DrQ6C7
Scope of the Report:
In the last several years, global market of Equine Pharmaceuticals and Supplements developed rapidly, with an average growth rate of 4.52% during 2013 to 2017. In 2017, global revenue of Equine Pharmaceuticals and Supplements is nearly 977 M USD; the actual production is…
